Physician profile
Robert M Samstein
NPI 1134547136
$124,694.36
in general payments reported to CMS, 2019-2025
8 companies · $1,147 in 2025
The $1,147 reported for 2025 was more than what 85% of Radiation Oncology providers received nationally (typical 2025 total: $172).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $110K · 2020: $11K · 2021: $2,570 · 2022: $131 · 2023: $62.48 · 2024: $118 · 2025: $1,147.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $769 · Food and Beverage: $559.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $769.07 |
| Food and Beverage | $559.20 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $119,060.00 | 2019-2020 | |
| Gilead Sciences, INC. | $2,570.00 | 2021 | |
| Regeneron Pharmaceuticals, INC. | $1,605.00 | 2020 | |
| Intuitive Surgical, INC. | $1,147.41 | 2025 | |
| Amgen INC. | $131.09 | 2022 | |
| Jazz Pharmaceuticals INC. | $118.38 | 2024 | |
| Cti Biopharma Corp. | $62.48 | 2023 | Vonjo |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Samstein listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.